Page 1 of Clinical Trials for "Hemosiderosis", 20 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis
Last Updated: May 5, 2010
Condition(s): Beta-Thalassemia; Hemosiderosis
2
Completed
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
Last Updated: August 28, 2011
Condition(s): Beta-thalassemia Major; Hemosiderosis; Iron Overload; Rare Anemia
3
Completed
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Last Updated: April 27, 2012
Condition(s): Chronic Anemia; Transfusional Hemosiderosis
4
Recruiting
Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox
Last Updated: April 27, 2012
Condition(s): Transfusional Hemosiderosis
5
Completed
Safety, Tolerability, and Efficacy of Deferasirox in MDS
Last Updated: November 24, 2010
Condition(s): Myelodysplastic Syndromes; Hemosiderosis
6
Completed
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Last Updated: April 15, 2011
Condition(s): Anemia; Hemosiderosis
7
Completed
Efficacy Study in Removing Excess Iron From the Heart
Last Updated: March 13, 2007
Condition(s): Thalassemia Major; Hemosiderosis
8
Not yet recruiting
Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
Last Updated: February 3, 2012
Condition(s): Beta-thalassemia Major; Sickle Cell Disease; Iron Hemosiderosis
9
Recruiting
Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
Last Updated: April 13, 2012
Condition(s): Transfusional Iron Overload; Transfusional Hemosiderosis
10
Recruiting
Non-invasive Quantification of Liver Iron With MRI
Last Updated: January 19, 2012
Condition(s): Iron Overload; Hemosiderosis
11
Completed
Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
Last Updated: April 27, 2012
Condition(s): Transfusional Hemosiderosis
12
Completed
Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
Last Updated: February 25, 2011
Condition(s): Anemia, Sickle Cell
13
Completed
Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions
Last Updated: April 18, 2012
Condition(s): Beta-Thalassemia
14
Recruiting
PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood
Last Updated: April 3, 2008
Condition(s): Central Alveolar Hypoventilation Syndrome
15
Active, not recruiting
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
Last Updated: June 22, 2011
Condition(s): Anemia
16
Completed
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Last Updated: March 2, 2011
Condition(s): Beta-thalassemia; Myelodysplastic Syndromes; Fanconi Syndrome; Anemia, Diamond-Blackfan; Anemia, Aplastic
17
Completed
Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).
Last Updated: May 3, 2011
Condition(s): Sickle Cell Disease
18
Completed
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
Last Updated: November 2, 2011
Condition(s): Myelodysplastic Syndromes; Transfusion Dependent Iron Overload
19
Completed
A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity
Last Updated: January 6, 2010
Condition(s): Transfusional Iron Overload
20
Completed
Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Last Updated: March 7, 2012
Condition(s): Iron Overload

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Hemosiderosis%22

Page 1 of Clinical Trials for "Hemosiderosis", 20 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About